Industrial Pharmacy
SADC Regional Industrial Pharmacy Fellowship
Shaping an inclusive and responsive ecosystem for regional industrial pharmacy development
The project for SADC Industrial Pharmacy Fellowship Programme is a component of the Joint Action “Support towards Industrialisation and the Productive Sectors (SIPS) in the SADC Region”. The project supports the development of selected regional value chains linked to the SADC Industrialisation strategy to enhance effective industry-knowledge clusters involving the private sector and knowledge institutions to develop or improve academic programmes that address the existing skills gap in the regional antiretroviral value chain.
The SADC Industrial Pharmacy Fellowship Programme will be developed, providing specialised training at the master’s level for building training capacity for certain aspects of pharmaceutical production, The programme will be supported through a governance and management framework that promotes linkages between private-sector pharmaceutical manufacturers and academic institutions in programme design, delivery and monitoring and review.
SARUA will provide oversight and advisory services for the development of the SIPS Fellowship.
Prof René Pellissier | [email protected]
Ms Megan Goddard | [email protected]
Project rationale, purpose and anticipated outcomes
Master’s level programme for training capacity in pharmaceutical production:
Supported by a governance and management framework that promotes linkages between private-sector pharmaceutical manufacturers and academic institutions in programme design, delivery and monitoring and review.
SARUA Programme aim and deliverables
Aim
To provide oversight, facilitatory and advisory services and support coordination activities during the development and implementation of the SADC Industrial Pharmacy Fellowship.
Deliverables
- A report on the effectiveness of the current Fellowship Programme.
- Three advisory notes relating to the strategic alignment of the Fellowship Programme.
- A proposed qualification standard for a regional master’s degree in Industrial Pharmacy.
- Governance and management structures for the Regional Fellowship Programme.
- Materials (including visual aids) to support communication and liaison with key role players in the SADC.
- A coordination strategy to support stakeholder engagement.
- A learning and innovation strategy to support the up-scaling of the Programme.
- Arrangement of meetings of the SIPS Advisory Committee and Technical Working Group and development of meeting agendas and minutes.
SARUA’s Fellowship team
| Person | Specialisation | Contribution |
|---|---|---|
| Prof René Pellissier Team Lead SARUA |
Prof of Research and Innovation, Prof of Information Sciences Industrial Eng specialising in Strategy and Systems |
Project Management |
| Dr Marianne Bester Univ of Stellenbosch (SA) |
Key Expert 1 | Programme Design |
| Prof Ilse Truter Professor in Pharmacy; Nelson Mandela University (SA) |
Key Expert 2 (Short-Term) (Disciplinary Expert) Member of SA Pharmaceutical Council (SAPC) |
Development of the body of knowledge to inform the programme. |
| Dr Mutenta Nyambe Lusaka Apex Medical University (Zambia) |
Key Expert 3 (Short-Term) (Disciplinary Expert) Dean: Faculty of Pharmacy, Nutrition and Dietetics |
Development of the body of knowledge to inform the programme. |
| Dr. Sr. John-Mary Vianney Nelson Mandela African Institute of Science and Technology (Tanzania) |
Key Expert 4 (Short-term) (Regional Health Care Expert). School of Life Sciences, Faculty of Life Sciences and Bio-Engineering |
Development of the body of knowledge to inform the programme. |
| Prof MJ Oosthuizen SARUA |
Key expert 5 (SADC Policies and Plans, and QA) | SADC Policy Environment and Regulatory Systems, including the relationship of the Industrial Pharmacy Fellowship Programme to the SADC University of Transformation |
| Ms Megan Goddard | Programme secretariat |
Fellowship monitoring and evaluation mechanisms
Fellowship operational design
Industrial pharmacy concepts
Industrial pharmacy is a branch of pharmacy concerned with the development, production, and quality control of pharmaceutical products on a large scale. It involves the application of pharmaceutical science and technology to the manufacturing processes in the pharmaceutical industry. The goal of industrial pharmacy is to ensure the efficient and safe production of pharmaceutical products that meet the required standards and regulatory requirements.
Value chains, refer to the series of activities that a company or industry undertakes to bring a product from its conception to the end consumer. It involves the coordination of various stages, including raw material sourcing, manufacturing, distribution, marketing, and customer service.
In the context of industrial pharmacy, value chains play a crucial role in the overall production and delivery of pharmaceutical products
Pharmaceutical value chain stages
- Research and Development (R&D): This stage involves the discovery and development of new drug molecules or the improvement of existing drugs. It includes activities such as drug discovery, preclinical testing, and clinical trials.
- Manufacturing: Once a drug has been developed and approved, the manufacturing stage begins. It involves large-scale production of pharmaceutical products, including drug formulation, packaging, and quality control. Manufacturing facilities must comply with Good Manufacturing Practices (GMP) to ensure product safety and quality.
- Supply Chain Management: This stage involves managing the flow of raw materials, intermediates, and finished products from suppliers to manufacturers and then to distributors or wholesalers. It includes activities such as procurement, logistics, inventory management, and order fulfillment.
- Distribution: Pharmaceutical products need to be efficiently distributed from manufacturing facilities to pharmacies, hospitals, and other healthcare providers. This stage involves transportation, warehousing, and managing distribution networks to ensure timely and secure delivery.
- Marketing and Sales: Once the products reach the market, pharmaceutical companies engage in marketing and sales activities to promote their products to healthcare professionals and end consumers. This includes advertising, sales force activities, and educational initiatives. This stage involves activities related to patient care, such as providing information about drug usage, monitoring adverse drug reactions, and ensuring the safe and effective use of pharmaceutical products.
Each stage in the pharmaceutical value chain contributes to the overall quality, safety, and availability of pharmaceutical products. Effective management and coordination across these stages are essential to ensure the efficient and reliable supply of medicines to patients.
